Overview
Techdow Pharma Poland is part of Shenzhen Techdow Pharmaceutical Co., Ltd., a manufacturer and supplier of the active ingredient enoxaparin sodium, exported to more than 40 countries. In Poland, the company promotes and intermediates the distribution of the first biosimilar enoxaparin sodium registered in Europe, available to Polish patients.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The only member of the management board represents the company independently. In the case of a multi-member management board, the company is represented by each member of the management board independently, subject to the following sentence. With respect to acts resulting in the disposal of a right or the assumption of an obligation to render a performance with a value exceeding PLN 250,000 (in words: two hundred and fifty thousand zlotys), within a single transaction or a series of transactions, the joint action of two members of the management board is required. For continuing obligations, a period of one year is relevant when verifying the aforementioned monetary threshold.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Techdow (hong Kong) Limited | 14,718 | $1,987,844.41 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-10-14.
91 1030 1508 0000 0008 1843 2051- 29 1030 1508 0000 0008 1843 2003
- 05 1030 1508 0000 0008 1843 2047
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,314$9,314 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $43,814$43,814 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,314$9,314 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitamed Pharmaceuticalssp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| Pharmabestsp. z o.o. | $13,942,252.57 | pharmabest.pl | ||
| POL-NILsp. z o.o. | $9,170,055.52 | pol-nil.com.pl | ||
| Prodpolsp. z o.o. | $8,498,232.41 | prodpol.pl | ||
| Simply You Polandsp. z o.o. | $7,463,283.82 | simply-you.pl | ||
| Biochem PolskaS.A. | $7,311,179.43 | biochempolska.pl | ||
| Chem4polsp. z o.o. | $6,926,177.18 | chem4pol.pl | ||
| Pharm Supplysp. z o.o. | $6,901,751.00 | pharmsupply.com.pl | ||
| Chemix Groupsp. z o.o. | $3,489,223.26 | chemixgroup.pl | ||
| GWS Polandsp. z o.o. | $2,706,990.11 | gwspoland.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-11-26 | Share capital change (50,000.00 PLN → 7,359,000.00 PLN) | |
| 2017-08-03 | Address change (Plac Marsz. Józefa Piłsudskiego 1, 00-078, Warszawa → Ul. Taneczna 18, 02-829, Warszawa) | |
| 2016-10-12 | Entered in the register |
FAQ
Last updated: 2026-10-07